On this page
- TL;DR
- Female sexual arousal disorder VA rating under DC 7632
- SMC-K: how VA pays for female sexual arousal disorder
- Is female sexual arousal disorder service connected?
- The FSAD C&P exam
- Why VA denies female sexual arousal disorder claims
- Questions veterans ask about female sexual arousal disorder
- Bottom Line
Female sexual arousal disorder (FSAD) has one schedular evaluation under Diagnostic Code 7632: 0 percent. The footnote to 38 CFR § 4.116 (opens in a new tab) directs VA to review entitlement to special monthly compensation under § 3.350 (opens in a new tab).
The 0-percent evaluation recognizes a service-connected disability but does not create standard schedular compensation by itself. SMC-K may provide separate compensation when the evidence establishes qualifying service-connected loss or loss of use of a creative organ. It should be reviewed, not promised automatically.
TL;DR
- DC 7632 assigns FSAD a single 0-percent schedular rating, and 0 percent is the most the schedule allows.
- The footnote to DC 7632 tells VA to review SMC-K under § 3.350, the monthly payment for loss of use of a creative organ. That payment, not the rating, is where an FSAD claim pays.
- VA's adjudication manual lets VA award SMC-K when FSAD is diagnosed, so the diagnosis has to be in the record.
- Possible service-connection routes include direct onset, service-connected mental health conditions, medication effects, and physical or gynecological conditions.
- Military sexual trauma is an in-service event, not itself a disability rating; the medical opinion must connect the diagnosed FSAD to the event, a resulting service-connected condition, or treatment.
- Pain, arousal difficulty, orgasmic difficulty, and low desire are not interchangeable and may require different diagnoses.
- Denial is the most common Board outcome on FSAD. In the 2025 decisions I read, most denials were appeals for a rating above 0 percent, and the service connection denials found no current FSAD diagnosis.
Female sexual arousal disorder VA rating under DC 7632
DC 7632 lists "female sexual arousal disorder (FSAD)" at 0 percent, with a footnote that reads "Review for entitlement to special monthly compensation under § 3.350 of this chapter." Unlike many gynecological codes, it has no 10-, 30-, or 50-percent ladder. Note 2 at the top of § 4.116 adds that any claim involving loss or loss of use of a creative organ should be checked against § 3.350.
That ceiling is why appealing the 0 percent does not help. In the 2025 Board decisions I read, most FSAD denials were appeals for a rating above 0 percent, and the Board's answer was that DC 7632 has no higher level (for example, Citation Nr. A25008339, where the veteran already received SMC-K). The SMC-K review below is the part of the claim to press.
VA's Women Veterans Health Care sexual health page (opens in a new tab) lists difficulty with arousal as one of four common concerns, alongside low desire, difficulty with orgasm and sexual pain. It notes that medical conditions, certain medications, hormonal changes, surgery or radiation, depression, PTSD and sexual trauma can all play a part. Those associations help identify a theory, but a compensation claim still needs a clinician to identify the diagnosis and the most likely cause or aggravating factor.
Rating FSAD alongside other gynecological conditions
38 CFR § 4.14 (opens in a new tab) bars evaluating the same manifestation under different diagnoses. A veteran may have FSAD and another gynecological diagnosis, such as residuals of a hysterectomy or endometriosis, but the evidence must separate arousal impairment from pain, bleeding, surgical residuals, or another already-rated function. When it does, the two can be rated separately; in one 2025 decision the veteran held separate ratings for adhesions and for FSAD associated with them (Citation Nr. A25046800).
SMC-K: how VA pays for female sexual arousal disorder
Special monthly compensation under 38 U.S.C. § 1114(k) is payable for "each anatomical loss or loss of use of" one or more creative organs, and § 3.350(a) says it "is payable in addition to the basic rate of compensation otherwise payable on the basis of degree of disability." For FSAD, that payment is the money, even though the rating itself is 0 percent.
VA's adjudication manual speaks to FSAD directly. As the Board quoted it in a June 2025 decision, the M21-1 "provides that special monthly compensation may be awarded where there is a diagnosis of Female Sexual Arousal Disorder (FSAD)," which it describes as a continual or recurrent physical inability to reach or keep the lubrication-swelling response during sex (Citation Nr. A25048556, citing M21-1 V.iii.8.A.1.e). In that same decision, the Board denied SMC-K because the record held no FSAD diagnosis.
VA decides SMC-K as part of the FSAD claim under 38 CFR § 3.155(d)(2), so no separate claim is needed. The SMC rate changes each year, so check VA's current compensation-rate page for the amount.
What the record needs for SMC-K
The record should show the diagnosis, the functional loss, its medical cause, its persistence despite treatment, and its connection to service. Section 3.350(a)(1)(iii) bars SMC-K for loss of use traceable to an elective operation after service, but an operation "advised on sound medical judgment for the relief of a pathological condition or to prevent possible future pathological consequences" is not elective. In an April 2025 decision, the Board granted FSAD and SMC-K after the veteran's dermatologist pressed for a tubal ligation because the veteran's psoriasis medication could cause birth defects, and it found the surgery was not elective in that setting (Citation Nr. A25030916).
Is female sexual arousal disorder service connected?
Direct service connection
Under § 3.303 (opens in a new tab), direct service connection may apply when FSAD began during service or a clinician links it to an in-service disease, injury, procedure, or personal assault. A trauma-informed medical evaluation is particularly important when the theory involves military sexual trauma.
The South Central MIRECC's sexual health after military sexual trauma brochures (opens in a new tab) separate women's sexual problems into desire, arousal, orgasm, pain and satisfaction, and note that they are more common among women veterans with depression or PTSD. The diagnosis and nexus should identify which impairment is present rather than assume every post-trauma sexual concern is FSAD.
Secondary to PTSD, depression or medication
A claim under § 3.310 (opens in a new tab) may argue that service-connected PTSD, depression, or medication used to treat a service-connected condition caused FSAD or aggravated it, meaning it would be less severe but for that condition. An opinion that addresses causation and skips aggravation is inadequate (El-Amin v. Shinseki, 26 Vet. App. 136 (2013)).
The medical link is plausible but indirect. In a survey of 464 trauma-exposed female service members and veterans, more severe PTSD went with lower arousal and lubrication function, and the link ran through depression and lower relationship satisfaction (Blais and colleagues, Journal of Affective Disorders, 2022, PMID 34965403). That was a cross-sectional survey, an association rather than proof of cause, so the opinion should explain the path in your own records.
Medication claims are stronger with prescription records, the start or dose-change date, symptom timing, and a prescriber's explanation. A package insert showing a possible side effect does not by itself establish causation in one veteran. The erectile dysfunction secondary to PTSD page covers the parallel claim for men and its Board results, and secondary conditions to PTSD lists the others.
Secondary to a physical or gynecological condition
VA's women's health page names diabetes, high blood pressure, cancer, surgery or radiation, and hormonal changes among the causes of sexual health problems. The Board has seen FSAD as a residual of a hysterectomy (Citation Nr. A25002023) and service connected in relation to an ovarian cyst (Citation Nr. A25032658). The opinion should distinguish arousal impairment from pain, scarring, hormonal symptoms, or loss of reproductive organs that may be evaluated under different codes.
The FSAD C&P exam
VA usually examines FSAD on the gynecological conditions exam, and sometimes on a mental health exam when the claim runs through PTSD (Citation Nr. A25004438). The Gynecological Conditions DBQ guide explains what the form records. The record should answer these questions.
- What sexual-function diagnosis has the clinician made?
- Is the problem arousal, desire, orgasm, pain, or a combination?
- When did it begin, and has it persisted?
- Is it caused or aggravated by trauma, a service-connected condition, medication, surgery, or another medical condition?
- What competing causes were considered?
- What treatments were tried, and what functional impairment remains?
- Does the evidence support loss or loss of use of a creative organ for SMC review?
Go to the exam. In one 2025 denial, the veteran refused one scheduled exam and missed another, and the Board decided the claim on the existing record, which showed no FSAD (Citation Nr. A25004438).
Why VA denies female sexual arousal disorder claims
Across 213 decided Board rulings on female sexual arousal disorder from 2021 to 2026, 23.9% were granted, 43.2% denied and 32.9% remanded. A ruling is one issue the Board decided in one decision; one decision often rules on several issues. That grant rate is 0.8 percentage points below the 24.7 percent across all decided Board rulings, and denial is the most common outcome.
The same gaps repeat in the 2025 decisions I read.
- No current diagnosis. Each FSAD service connection denial I read found no current FSAD diagnosis. In one, the VA examiner wrote that the veteran's report of FSAD was "subjective only," with no objective findings or treatment in the file (Citation Nr. A25018522).
- Low libido counted in the mental health rating. When the only finding is reduced sex drive from PTSD, the Board has treated it as part of the psychiatric rating rather than as FSAD (Citation Nr. A25048556).
- Appealing the 0 percent. DC 7632 has no higher level, so an appeal for more than 0 percent fails. The issue to press is SMC-K.
- Calling MST the diagnosis. MST is the in-service event; the claim still needs the resulting diagnosis and a nexus.
- A side-effect list instead of an opinion. A medication side-effect list without a case-specific timeline or opinion, or an opinion that never addresses aggravation.
- Duplicate ratings. Seeking separate ratings for overlapping sexual or gynecological manifestations.
Questions veterans ask about female sexual arousal disorder
What is the VA rating for female sexual arousal disorder?
Zero percent. DC 7632 assigns a single 0 percent rating for FSAD, and its footnote tells VA to review the claim for SMC-K under § 3.350.
Does VA pay for FSAD?
Not through the 0 percent rating itself. The payment comes from SMC-K, which is paid on top of your basic compensation when the evidence shows loss of use of a creative organ from service-connected FSAD.
Can female sexual arousal disorder be secondary to PTSD?
Yes, if a clinician diagnoses FSAD and explains how PTSD, or the medication that treats it, caused it or made it worse. Without the diagnosis the claim fails: in two 2025 decisions, the Board denied FSAD claimed as secondary to PTSD because the record held no FSAD diagnosis (Citation Nr. A25018522 and A25029159).
Do I have to file a separate claim for SMC-K?
No. Under 38 CFR § 3.155(d)(2), VA decides ancillary benefits such as SMC under § 3.350 as part of the claim, whether or not you ask. Naming SMC-K still helps make sure the rater addresses it.
Is low libido the same as female sexual arousal disorder?
No. Low desire, arousal difficulty, orgasm problems and pain are different concerns, and FSAD is the arousal impairment. When reduced sex drive comes from PTSD or depression, the Board has treated it as part of the mental health rating unless a clinician diagnoses FSAD separately.
Bottom Line
FSAD is rated at 0 percent under DC 7632, the only level the code has, with a required review for SMC-K. The SMC-K review is where the claim pays, and it rests on a diagnosis: in the 2025 denials I read, the missing piece was the FSAD diagnosis itself. A strong claim documents the precise diagnosis, the functional loss, the timeline, treatment, and a medical explanation connecting the condition to service or a service-connected disability, including aggravation.
Methodology and Limitations
- Data source: 38 CFR §§ 4.116 (DC 7632 and its footnote), 3.350(a), 3.155(d)(2), 3.303, 3.310 and 4.14, checked against the eCFR text current to October 2, 2026. The M21-1 provision on FSAD is quoted from a Board decision that cites it (Citation Nr. A25048556). Sexual-health concerns come from VA's Women Veterans Health Care page and the South Central MIRECC brochure for women veterans, checked October 10, 2026. The PTSD finding cites a PubMed abstract by PMID.
- Sample size: Board figures come from Claim Raven's read of every Board decision from 2021 to 2026 that it holds, 510,968 decisions containing 1,376,193 rulings. That includes 213 decided Board rulings on female sexual arousal disorder (241 rulings in all, counting dismissed and withdrawn issues): 23.9% were granted, 43.2% denied and 32.9% remanded. This page shows only these overall figures; too few FSAD rulings support a finer breakdown. Board decisions cited by number come from my reading of 2025 decisions.
- Limitations: Board figures reflect appealed claims, not claims decided at the regional office. Board decisions cited by number are examples of reasoning, not predictions of individual outcomes. The SMC-K payment amount changes each year and is not stated here. Claim Raven is data analysis, not legal, medical, or VA-accredited advice.
